Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system, with a complex genetic background. Here, we present a genome screen for association in small scale, employing 11,555 single nucleotide polymorphisms (SNPs) on DNA chips for genotyping 100 MS patients stratified for HLA-DR2 + and 100 controls. More than 500 SNPs revealed significant differences between cases and controls before Bonferroni correction. A fraction of these SNPs was reanalysed in two additional cohorts of patients and controls, using high-throughput genotyping methods. A marker on chromosome 6p21.32 (rs2395182) yielded the highest significance level, validating the established HLA-DR association. © Springer-Verlag 2005.
CITATION STYLE
Gödde, R., Rohde, K., Becker, C., Toliat, M. R., Entz, P., Suk, A., … Epplen, J. T. (2005). Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips. Journal of Molecular Medicine, 83(6), 486–494. https://doi.org/10.1007/s00109-005-0650-8
Mendeley helps you to discover research relevant for your work.